University of Colorado Anschutz Medical Campus | Industry Collaboration Index

Why this position

Four pillars, as percentiles

Co-creation30% of the score

How often it co-authors with companies, compared with what its own mix of research fields would predict; size makes no difference. 1,215 verified works against about 879 expected for its fields (1.38 times the expected rate).

Durability20% of the score

How much of its industry work sits in sustained partnerships with the same company group. 57 sustained partnerships: five or more joint works in three or more of the five years.

Scale30% of the score

The size of its industry network: company groups on two or more works, sustained partnerships, and its place in the worldwide network of universities and companies. 189 company groups on two or more joint works; 57 sustained partnerships.

Breadth20% of the score

How varied its partners are, judged by each company's main research field. Measured across the main research fields of all the company groups it worked with.

Each pillar is a percentile among the 1,038 ranked universities: a value of 80 means a higher value than about 80 in every 100 of them. The ICI score (64.5) is the weighted average of the four percentiles. Rank 268 of 1,038 overall; 78 of 203 in United States; 85 of 231 in North America. Standing bands: Platinum for ranks 1 to 100, Gold 101 to 300, Silver 301 to 600. How the index is built →

In numbers

The evidence behind the position

6.0%of its 20,070 research works in 2021 to 2025 were co-authored with a verified company

1.38Industry co-authorship rate: 1.38 times what its mix of research fields would predict (1,215 verified works; about 879 expected)

57sustained partnerships: the same company group on five or more joint works in three or more of the five years

In United States

78 of 203 ranked universities in United States

#76 Rice University world #254, score 65.5
#77 Colorado School of Mines world #258, score 65.1
#78 University of Colorado Anschutz Medical Campus world #268, score 64.5
#79 University of Georgia world #290, score 63.2
#80 University of Alaska Fairbanks world #313, score 61.8

All ranked universities → North America: 85 of 231 →

Where it works with industry

Sector strengths

Verified industry works by sector, with its position in each sector ranking. A university is ranked in a sector once it has at least 20 verified works there; sectors with fewer than 50 eligible universities are provisional.

Strongest sector positions

#109 of 638Pharmaceuticals and Therapeutics280 verified works in the sector

#142 of 323Medical Technology and Digital Health50 verified works in the sector

Pharmaceuticals and Therapeutics

280#109 of 638

Medical Technology and Digital Health

50#142 of 323

Biotechnology and Advanced Therapies

32#171 of 220

Artificial Intelligence

5under 20 works

Software, Cloud and Data

4under 20 works

Climate, Environment and Sustainability

2.5under 20 works

Not in any of the 21 sectors

841.5counted in the overall index

373.5 of its 1,215 verified industry works fall within the 21 sectors. The rest have research topics that belong to no industry sector (basic science, for example) or are consortium papers with 100 or more authors, which the sector indices leave out; all of them count fully in the overall index.

Who it works with

Company partners, 2021 to 2025

University of Colorado Anschutz Medical Campus co-authored verified work with 518 company groups, consortium papers aside: 189 of them on two or more works, and 57 as sustained partners.

The largest 12 of its 518 company groups, by joint works

Company group	Based in	Company's main research field	Joint works	Years with a joint work
Westat	United States	Medicine	45	5 of 5
AstraZeneca	United Kingdom	Medicine	43.5	5 of 5
Merck & Co. (MSD)	United States	Medicine	35.5	5 of 5
Johnson & Johnson	United States	Medicine	33.5	5 of 5
Roche	Switzerland	Medicine	31.5	5 of 5
Bayer	Germany	Medicine	31	5 of 5
Pfizer	United States	Medicine	25	5 of 5
AbbVie	United States	Medicine	22	5 of 5
Eli Lilly	United States	Medicine	21.5	5 of 5
Regeneron	United States	Medicine	21	5 of 5
Novartis	Switzerland	Medicine	20	5 of 5
Bristol-Myers Squibb	United States	Medicine	20	5 of 5

A company group brings together a company's subsidiaries and research labs under one name. A work counts half when its only company author also holds a post at this university. Consortium papers with 100 or more authors are left out of this table.

Its largest partner accounts for 3% of its partnered work.
66% of its partnered work is with companies based in United States.
2% of its company links are to companies whose recorded address is within 50 km of the university. A recorded address is often a head office, so local sites of large companies are under-counted.
Less than 1% of its partnered work is with state-owned companies; the index counts them as industry when they sell goods or services, as the OECD Frascati Manual does, and marks each one.

Examples of its work with industry

Most-cited verified joint works

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial (2021, 1,384 citations; with Novo Nordisk)
Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRAS G12C Mutation (2022, 1,051 citations; with Mirati Therapeutics)
Sotatercept for the Treatment of Pulmonary Arterial Hypertension (2021, 616 citations; with Acceleron Pharma)
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas (2021, 388 citations; with Novartis, Aduro BioTech)
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study (2022, 359 citations; with Iovance Biotherapeutics)
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele (2021, 309 citations; with Vertex Pharmaceuticals)

Its most-cited verified works with 30 or fewer authors, leaving out guidelines and consensus statements. Citation counts are those of the open scholarly record at harvest. Each title links to the work.

Over time

Verified industry works by year

2202021

223.52022

2512023

2372024

283.52025

2025 is not yet complete: papers published late in the year are still being added to the open record, and coverage may not be equally complete for every university, so compare years with care. A work counts half when its only company author also holds a post at the university, so some totals end in .5.

Evidence checked

1,697 verified company links

Each counted link (one work, this university and one company) was confirmed against the affiliation text its author wrote; 1,386 of 3,083 candidate links were set aside.

Why links were set aside

607 company name not written in the author's affiliation
203 ordinary-word name without a company suffix
131 part of a university or public institute's own unit
106 a place or common word that failed its stricter rule
104 refresh_university_not_on_work
32 excluded after hand audit: Matched from social media handles in affiliation text
203 for other reasons: smaller hand-audit findings, and links the current open record no longer supports

If a partner is missing or should not be here, send the evidence; corrections are free and reviewed against the public record.

For your communications

Badges you can use

Use the badge with a link to this page.

GRP Partnership Intelligence Platform

Where University of Colorado Anschutz Medical Campus's collaboration could go next

This profile is free and public, and it stays that way. Beyond it, the GRP Partnership Intelligence Platform, a partner service arranged with each university, sets your record in both GRP indices beside the peers you choose: the universities and companies your peers work with that you do not, live funding calls matched to your strengths, the EU projects your peers have won, and a brief ready for your executive. It opens to partner universities on Monday 19 October 2026: enquire, and the GRP team will confirm availability and pricing for your university.

Request first access → See what is inside →

The platform cannot move any university's position, band or score.

The other GRP index

Research Collaboration Index

In the Research Collaboration Index 2026, University of Colorado Anschutz Medical Campus ranks #371 of 1,195, with Silver standing. It measures the whole research network, not only industry.

View the RCI profile →

Something wrong? Every figure comes from the public record and can be checked. If a partner is missing or should not be there, tell us and we will review it with the evidence. The 2027 edition will be calculated with the same published methodology. The window for universities to submit data for it is open now: submit data for the 2027 edition. The index is free, public and independent. No commercial relationship with any university or company changes any position, and no one can pay to be included, excluded or moved.